1. Home
  2. TMO vs BLK Comparison

TMO vs BLK Comparison

Compare TMO & BLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMO
  • BLK
  • Stock Information
  • Founded
  • TMO 1956
  • BLK 1988
  • Country
  • TMO United States
  • BLK United States
  • Employees
  • TMO N/A
  • BLK N/A
  • Industry
  • TMO Industrial Machinery/Components
  • BLK Investment Bankers/Brokers/Service
  • Sector
  • TMO Industrials
  • BLK Finance
  • Exchange
  • TMO Nasdaq
  • BLK Nasdaq
  • Market Cap
  • TMO 159.1B
  • BLK 153.9B
  • IPO Year
  • TMO N/A
  • BLK 1999
  • Fundamental
  • Price
  • TMO $419.93
  • BLK $1,088.04
  • Analyst Decision
  • TMO Buy
  • BLK Strong Buy
  • Analyst Count
  • TMO 17
  • BLK 13
  • Target Price
  • TMO $592.24
  • BLK $1,110.15
  • AVG Volume (30 Days)
  • TMO 2.7M
  • BLK 577.0K
  • Earning Date
  • TMO 07-23-2025
  • BLK 07-15-2025
  • Dividend Yield
  • TMO 0.41%
  • BLK 1.92%
  • EPS Growth
  • TMO 9.37
  • BLK 4.56
  • EPS
  • TMO 17.06
  • BLK 41.15
  • Revenue
  • TMO $42,898,000,000.00
  • BLK $20,955,000,000.00
  • Revenue This Year
  • TMO $2.94
  • BLK $16.03
  • Revenue Next Year
  • TMO $6.08
  • BLK N/A
  • P/E Ratio
  • TMO $24.61
  • BLK $26.43
  • Revenue Growth
  • TMO 0.95
  • BLK 14.23
  • 52 Week Low
  • TMO $385.46
  • BLK $773.74
  • 52 Week High
  • TMO $627.88
  • BLK $1,087.45
  • Technical
  • Relative Strength Index (RSI)
  • TMO 54.27
  • BLK 77.59
  • Support Level
  • TMO $415.42
  • BLK $1,070.00
  • Resistance Level
  • TMO $433.14
  • BLK $1,086.84
  • Average True Range (ATR)
  • TMO 11.45
  • BLK 16.14
  • MACD
  • TMO 2.50
  • BLK 6.21
  • Stochastic Oscillator
  • TMO 72.29
  • BLK 99.44

About TMO Thermo Fisher Scientific Inc

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).

About BLK BlackRock Inc.

BlackRock is the largest asset manager in the world, with $11.584 trillion in assets under management at the end of March 2025. Its product mix is diverse, with 53% of managed assets in equity strategies, 26% in fixed income, 9% in multi-asset classes, 8% in money market funds, and 4% in alternatives. Passive strategies account for two thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which by our calculations account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one third of managed assets coming from investors domiciled outside the US and Canada.

Share on Social Networks: